Nicolas Koutlidis
Research Subjects
Nicolas Koutlidis has a total of 306 co-authors. Here are the top co-authors by number of shared publications:
L. Cormier
CeRePP, 75020 Paris, France; Département de chirurgie urologique, CHU de Dijon, 21000 Dijon, France
9 shared publicationsP. Bigot
CHU d'Angers, Angers, France
9 shared publications- Jean-Christophe Bernhard
Urology Department, Bordeaux University Hospital, Bordeaux, France
8 shared publications Luc Cormier
Academic Department of Urology, CHU Dijon, Dijon, France
7 shared publicationsPierre Bigot
Academic Department of Urology, CHU Angers, Angers, France
6 shared publicationsChristian Pfister
Cancerology Committee of the French Association of Urology (CCAFU), Paris, France
4 shared publications
Latest Publications
- 1 July 2016
- Published by Elsevier in European Urology
- Vol. 70 (1) , 6-8
Impact of Body Mass Index, Age, Prostate Volume, and Genetic Polymorphisms on Prostate-specific Antigen Levels in a Control Population
- 1 July 2016
- Published by Elsevier in European Urology
- Vol. 70 (1) , 6-8
Impact of Body Mass Index, Age, Prostate Volume, and Genetic Polymorphisms on Prostate-specific Antigen Levels in a Control Population
- Open Access
- 30 March 2016
- Published by Hindawi Limited in Case Reports in Urology
- Vol. 2016, 1-4
Management of Testicular Silicone Gel-Filled Prosthesis Rupture: Case Report of a Rare Event and a Review of the Literature
Introduction. We report a case of spontaneous rupture of a single testicular prosthesis in a patient who had undergone bilateral orchiectomy and silicone gel-filled prosthesis insertion. The consequences of this rare event are discussed. There is no management algorithm.Case Presentation. A 55-year-old man presented to our outpatient department with altered consistency in his right testicular prosthesis and a painful right hemiscrotum with no systemic symptoms thirty-three years after the implantation of the prosthesis. We removed this implant without replacement, in accordance with the patient’s wishes.Conclusion. The long time between the implantation and the spontaneous rupture is remarkable and was never before described. The removal of the prosthesis was straightforward and it would have been possible to implant a new prosthesis after taking into account the condition of the skin.
- 30 March 2016
- Published by Hindawi Limited in Case Reports in Urology
- Vol. 2016, 1-4
Open AccessManagement of Testicular Silicone Gel-Filled Prosthesis Rupture: Case Report of a Rare Event and a Review of the Literature
Introduction. We report a case of spontaneous rupture of a single testicular prosthesis in a patient who had undergone bilateral orchiectomy and silicone gel-filled prosthesis insertion. The consequences of this rare event are discussed. There is no management algorithm.Case Presentation. A 55-year-old man presented to our outpatient department with altered consistency in his right testicular prosthesis and a painful right hemiscrotum with no systemic symptoms thirty-three years after the implantation of the prosthesis. We removed this implant without replacement, in accordance with the patient’s wishes.Conclusion. The long time between the implantation and the spontaneous rupture is remarkable and was never before described. The removal of the prosthesis was straightforward and it would have been possible to implant a new prosthesis after taking into account the condition of the skin.
- 1 November 2015
- Published by Elsevier in Progrès en Urologie
- Vol. 25 (13) , 800
Cancer du rein cliniquement localisé : quels sont les facteurs prédictifs du risque d’upstaging pathologique pT3a par invasion de la graisse ?
- 1 November 2015
- Published by Elsevier in Progrès en Urologie
- Vol. 25 (13) , 800
Cancer du rein cliniquement localisé : quels sont les facteurs prédictifs du risque d’upstaging pathologique pT3a par invasion de la graisse ?
- 7 July 2015
- Published by Springer Nature in World Journal of Urology
- Vol. 34 (3) , 347-352
The subclassification of papillary renal cell carcinoma does not affect oncological outcomes after nephron sparing surgery
Objectives To evaluate the oncological outcomes of papillary renal cell carcinoma (pRCC) following nephron sparing surgery (NSS) and to determine whether the subclassification type of pRCC could be a prognostic factor for recurrence, progression, and specific death. Materials and methods An international multicentre retrospective study involving 19 institutions and the French network for research on kidney cancer was conducted after IRB approval. We analyzed data of all patients with pRCC who were treated by NSS between 2004 and 2014. Results We included 486 patients. Tumors were type 1 pRCC in 369 (76 %) cases and type 2 pRCC in 117 (24 %) cases. After a mean follow-up of 35 (1–120) months, 8 (1.6 %) patients experienced a local recurrence, 12 (1.5 %) had a metastatic progression, 24 (4.9 %) died, and 7 (1.4 %) died from cancer. Patients with type I pRCC had more grade II (66.3 vs. 46.1 %; p < 0.001) and less grade III (20 vs. 41 %; p < 0.001) tumors. Three-year estimated cancer-free survival (CFS) rate for type 1 pRCC was 96.5 % and for type 2 pRCC was 95.1 % (p = 0.894), respectively. Three-year estimated cancer-specific survival rate for type 1 pRCC was 98.4 % and for type 2 pRCC was 97.3 % (p = 0.947), respectively. Tumor stage superior to pT1 was the only prognostic factor for CFS (HR 3.5; p = 0.03). Conclusion Histological subtyping of pRCC has no impact on oncologic outcomes after nephron sparing surgery. In this selected population of pRCC tumors, we found that tumor stage is the only prognostic factor for cancer-free survival.
- 7 July 2015
- Published by Springer Nature in World Journal of Urology
- Vol. 34 (3) , 347-352
The subclassification of papillary renal cell carcinoma does not affect oncological outcomes after nephron sparing surgery
Objectives To evaluate the oncological outcomes of papillary renal cell carcinoma (pRCC) following nephron sparing surgery (NSS) and to determine whether the subclassification type of pRCC could be a prognostic factor for recurrence, progression, and specific death. Materials and methods An international multicentre retrospective study involving 19 institutions and the French network for research on kidney cancer was conducted after IRB approval. We analyzed data of all patients with pRCC who were treated by NSS between 2004 and 2014. Results We included 486 patients. Tumors were type 1 pRCC in 369 (76 %) cases and type 2 pRCC in 117 (24 %) cases. After a mean follow-up of 35 (1–120) months, 8 (1.6 %) patients experienced a local recurrence, 12 (1.5 %) had a metastatic progression, 24 (4.9 %) died, and 7 (1.4 %) died from cancer. Patients with type I pRCC had more grade II (66.3 vs. 46.1 %; p < 0.001) and less grade III (20 vs. 41 %; p < 0.001) tumors. Three-year estimated cancer-free survival (CFS) rate for type 1 pRCC was 96.5 % and for type 2 pRCC was 95.1 % (p = 0.894), respectively. Three-year estimated cancer-specific survival rate for type 1 pRCC was 98.4 % and for type 2 pRCC was 97.3 % (p = 0.947), respectively. Tumor stage superior to pT1 was the only prognostic factor for CFS (HR 3.5; p = 0.03). Conclusion Histological subtyping of pRCC has no impact on oncologic outcomes after nephron sparing surgery. In this selected population of pRCC tumors, we found that tumor stage is the only prognostic factor for cancer-free survival.
- 1 June 2015
- Published by Elsevier in Journal of Pediatric Urology
- Vol. 11 (3) , 113-117
Management of simple renal cyst in children: French multicenter experience of 36 cases and review of the literature
- 1 June 2015
- Published by Elsevier in Journal of Pediatric Urology
- Vol. 11 (3) , 113-117
Management of simple renal cyst in children: French multicenter experience of 36 cases and review of the literature
- 1 June 2015
- Published by Elsevier in Progrès en Urologie
- Vol. 25 (7) , 390-395
Marges chirurgicales des cancers de prostate à haut risque en prostatectomie totale robot-assistée
- 1 June 2015
- Published by Elsevier in Progrès en Urologie
- Vol. 25 (7) , 390-395
Marges chirurgicales des cancers de prostate à haut risque en prostatectomie totale robot-assistée
- 1 April 2015
- Published by Wolters Kluwer Health in Journal of Urology
- Vol. 193 (4S)
MP63-15 THE SUBCLASSIFICATION OF PAPILLARY RENAL CELL CARCINOMA DOES NOT AFFECT ONCOLOGICAL OUTCOMES AFTER NEPHRON SPARING SURGERY.
- 1 April 2015
- Published by Wolters Kluwer Health in Journal of Urology
- Vol. 193 (4S)
MP63-15 THE SUBCLASSIFICATION OF PAPILLARY RENAL CELL CARCINOMA DOES NOT AFFECT ONCOLOGICAL OUTCOMES AFTER NEPHRON SPARING SURGERY.
- 1 April 2015
- Published by Elsevier in European Urology Supplements
- Vol. 14 (2) , e307-e307a
307 The sub-classification of papillary renal cell carcinoma does not affect oncological outcomes after nephron sparing surgery
- 1 April 2015
- Published by Elsevier in European Urology Supplements
- Vol. 14 (2) , e307-e307a
307 The sub-classification of papillary renal cell carcinoma does not affect oncological outcomes after nephron sparing surgery